Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Levente Molnár

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Journal of Clinical Medicine|November 9, 2024
Midterm Outcome of Balloon-Expandable Covered Stenting of Femoral Access Site ComplicationsAndrás Szentiványi, Sarolta Borzsák, András Süvegh, et al.
Plos One|May 17, 2012
Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individualsJulianna Lisziewicz, Nyasha Bakare, Sandra A Calarota, et al.
Orvosi Hetilap|January 4, 2026
[Recanalization of chronic total coronary occlusion via transradial access]Tímea Szigethi, Dorottya Olajos, Levente Molnár, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 15, 2015
The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapyAndrás Mihály Boros, Gábor Széplaki, Péter Perge, et al.
Frontiers in Genetics|July 12, 2021
A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent SubjectsEszter Somogyi, Zsolt Csiszovszki, Levente Molnár, et al.
Frontiers in Cardiovascular Medicine|January 27, 2023
Predicting the survival benefit of cardiac resynchronization therapy with defibrillator function for non-ischemic heart failure-Role of the Goldenberg risk scoreEperke D Merkel, Walter R Schwertner, Anett Behon, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 11, 2013
DermAll nanomedicine for allergen-specific immunotherapyEdina Garaczi, Kornélia Szabó, László Francziszti, et al.
Interventional Medicine & Applied Science|September 22, 2017
The impact of cardiac resynchronization therapy on routine laboratory parametersAndrás Mihály Boros, Péter Perge, Klaudia Vivien Nagy, et al.
Frontiers in Cardiovascular Medicine|May 26, 2022
Switching From Proximal to Distal Radial Artery Access for Coronary Chronic Total Occlusion RecanalizationAlexandru Achim, Tímea Szigethy, Dorottya Olajos, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 29, 2017
Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patientsKlaudia Vivien Nagy, Gábor Széplaki, Péter Perge, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Journal of Clinical Medicine|November 9, 2024
Midterm Outcome of Balloon-Expandable Covered Stenting of Femoral Access Site ComplicationsAndrás Szentiványi, Sarolta Borzsák, András Süvegh, et al.
Plos One|May 17, 2012
Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individualsJulianna Lisziewicz, Nyasha Bakare, Sandra A Calarota, et al.
Orvosi Hetilap|January 4, 2026
[Recanalization of chronic total coronary occlusion via transradial access]Tímea Szigethi, Dorottya Olajos, Levente Molnár, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 15, 2015
The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapyAndrás Mihály Boros, Gábor Széplaki, Péter Perge, et al.
Frontiers in Genetics|July 12, 2021
A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent SubjectsEszter Somogyi, Zsolt Csiszovszki, Levente Molnár, et al.
Frontiers in Cardiovascular Medicine|January 27, 2023
Predicting the survival benefit of cardiac resynchronization therapy with defibrillator function for non-ischemic heart failure-Role of the Goldenberg risk scoreEperke D Merkel, Walter R Schwertner, Anett Behon, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 11, 2013
DermAll nanomedicine for allergen-specific immunotherapyEdina Garaczi, Kornélia Szabó, László Francziszti, et al.
Interventional Medicine & Applied Science|September 22, 2017
The impact of cardiac resynchronization therapy on routine laboratory parametersAndrás Mihály Boros, Péter Perge, Klaudia Vivien Nagy, et al.
Frontiers in Cardiovascular Medicine|May 26, 2022
Switching From Proximal to Distal Radial Artery Access for Coronary Chronic Total Occlusion RecanalizationAlexandru Achim, Tímea Szigethy, Dorottya Olajos, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 29, 2017
Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patientsKlaudia Vivien Nagy, Gábor Széplaki, Péter Perge, et al.
Pageof 6